AHL
IRWD icon

Abel Hall LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Abel Hall LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$54.4K Buy
13,707
+257
+2% +$1.07K 0.01% 831
2026
Q2 		$56.6K Buy
13,450
+542
+4% +$2.09K 0.01% 893
2026
Q1 		$45.3K Sell
12,908
-3,753
-23% -$15.4K 0.01% 750
2025
Q4 		$56.1K Buy
+16,661
New +$43.3K 0.01% 651

Other funds holding IRWD

CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Abel Hall LLC's IRWD Position: Q3 2026 in Review

Abel Hall LLC increased its Ironwood Pharmaceuticals (IRWD) stake by 1.9% in Q3 2026, buying an estimated $1.07K and bringing the position to 13,707 shares worth $54.4K. The position accounts for 0.01% of the portfolio, ranked #831.

Abel Hall LLC first reported a position in IRWD in Q4 2025 and has held it in 4 quarters since. The position peaked at $56.6K in Q2 2026. 21 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Abel Hall LLC held 13,707 shares of Ironwood Pharmaceuticals worth $54.4K as of Q3 2026.
  • Abel Hall LLC bought 257 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $1.07K.
  • Ironwood Pharmaceuticals made up 0.01% of Abel Hall LLC's portfolio in Q3 2026, its #831 holding.
  • Abel Hall LLC first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Ironwood Pharmaceuticals position peaked at $56.6K in Q2 2026.
  • 21 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.